Treatment of benign cephalic histiocytosis with topical 1% rapamycin ointment

Kaiane Habeshian, Robert A. Silverman, Cynthia M.C. DeKlotz

Research output: Contribution to journalArticle

Abstract

We report a pediatric case of extensive, progressive benign cephalic histiocytosis (BCH) involving the face, trunk, and extremities with response of facial lesions to treatment with topical 1% rapamycin. A split-face model was used to demonstrate improvement on the treated side versus the untreated side. After physician and parental perception of effectiveness, based in part on photodocumentation, subsequently both cheeks were treated with continued improvement.

Original languageEnglish (US)
JournalPediatric Dermatology
DOIs
StatePublished - Jan 1 2019

Fingerprint

Histiocytosis
Sirolimus
Ointments
Head
Cheek
Extremities
Pediatrics
Physicians
Therapeutics

Keywords

  • histiocytic disorders
  • neoplasms-benign
  • therapy-topical

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Dermatology

Cite this

Treatment of benign cephalic histiocytosis with topical 1% rapamycin ointment. / Habeshian, Kaiane; Silverman, Robert A.; DeKlotz, Cynthia M.C.

In: Pediatric Dermatology, 01.01.2019.

Research output: Contribution to journalArticle

Habeshian, Kaiane ; Silverman, Robert A. ; DeKlotz, Cynthia M.C. / Treatment of benign cephalic histiocytosis with topical 1% rapamycin ointment. In: Pediatric Dermatology. 2019.
@article{90d01663c87248b7977898cb5f458b4e,
title = "Treatment of benign cephalic histiocytosis with topical 1{\%} rapamycin ointment",
abstract = "We report a pediatric case of extensive, progressive benign cephalic histiocytosis (BCH) involving the face, trunk, and extremities with response of facial lesions to treatment with topical 1{\%} rapamycin. A split-face model was used to demonstrate improvement on the treated side versus the untreated side. After physician and parental perception of effectiveness, based in part on photodocumentation, subsequently both cheeks were treated with continued improvement.",
keywords = "histiocytic disorders, neoplasms-benign, therapy-topical",
author = "Kaiane Habeshian and Silverman, {Robert A.} and DeKlotz, {Cynthia M.C.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/pde.13800",
language = "English (US)",
journal = "Pediatric Dermatology",
issn = "0736-8046",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Treatment of benign cephalic histiocytosis with topical 1% rapamycin ointment

AU - Habeshian, Kaiane

AU - Silverman, Robert A.

AU - DeKlotz, Cynthia M.C.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - We report a pediatric case of extensive, progressive benign cephalic histiocytosis (BCH) involving the face, trunk, and extremities with response of facial lesions to treatment with topical 1% rapamycin. A split-face model was used to demonstrate improvement on the treated side versus the untreated side. After physician and parental perception of effectiveness, based in part on photodocumentation, subsequently both cheeks were treated with continued improvement.

AB - We report a pediatric case of extensive, progressive benign cephalic histiocytosis (BCH) involving the face, trunk, and extremities with response of facial lesions to treatment with topical 1% rapamycin. A split-face model was used to demonstrate improvement on the treated side versus the untreated side. After physician and parental perception of effectiveness, based in part on photodocumentation, subsequently both cheeks were treated with continued improvement.

KW - histiocytic disorders

KW - neoplasms-benign

KW - therapy-topical

UR - http://www.scopus.com/inward/record.url?scp=85063276593&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063276593&partnerID=8YFLogxK

U2 - 10.1111/pde.13800

DO - 10.1111/pde.13800

M3 - Article

C2 - 30907021

AN - SCOPUS:85063276593

JO - Pediatric Dermatology

JF - Pediatric Dermatology

SN - 0736-8046

ER -